Moderna | Les Charges D'Exploitation



Operating Expenses Changement Date
Acadia Pharmaceuticals USD 106.1M 112.66M 2024-12
Adcock Ingram Holdings ZAR 4.42B 268.95M 2024-06
Agios Pharmaceuticals USD 135.77M 1.11B 2024-12
Alnylam Pharmaceuticals USD 698.32M 120.5M 2024-12
Amgen USD 6.78B 401M 2024-12
Arrowhead Research USD 163.91M 1.71M 2024-12
Biogen USD 2.01B 13.3M 2024-12
BioMarin Pharmaceutical USD 585.91M 45.94M 2024-12
Celltrion KRW 674.25B 128.01B 2024-09
Cspc Pharmaceutical CNY 5.42B 102.74M 2024-09
Dianthus Therapeutics USD 33.24M 1.17M 2024-12
Gilead Sciences USD 5.12B 1.54B 2024-12
GlaxoSmithKline GBP 7.42B 402M 2024-12
Incyte USD 877.18M 114.6M 2024-12
Ionis Pharmaceuticals USD 337.4M 54.93M 2024-12
Kangmei Pharma CNY 1.46B 193.63M 2024-09
Knight Therapeutics CAD 89.06M 2.02M 2024-09
Laboratorios Farma EUR 311.35M 170.35M 2024-12
Malin Corporation EUR 700K 1.6M 2024-06
Moderna USD 2.21B 280M 2024-12
Organigram Holdings CAD 54.04M 9.62M 2024-12
Pharma Mar EUR 43.47M 3.3M 2024-12
Qiagen NV USD 377.04M 4.6M 2024-12
Regeneron Pharmaceuticals USD 2.8B 26.53B 2024-12
Sarepta Therapeutics USD 496.73M 51.76M 2024-12
Sartorius EUR 745.6M 21.2M 2025-03
Sino Biopharmaceutical CNY 11.66B 5.46B 2024-12
Tilray USD 253.17M 16.55M 2024-11
Ultragenyx Pharmaceutical USD 287.15M 15.67M 2024-12
United Therapeutics USD 378.2M 27.6M 2024-12
Vertex Pharmaceuticals USD 1.89B 230.4M 2024-12
Zz Pientze Pharmaceu 1.67B 86.7M 2024-09



Moderna Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.